Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Fagin

Showing results (1-10 of 261) with videos related to

Pageof 27
Sort By:
Public Policy|January 1, 1976
The policy implications of predictive decision-making: "likelihood" and "dangerousness" in civil commitment proceedingsA Fagin
Molecular Endocrinology (Baltimore, Md.)|May 1, 2002
Minireview: branded from the start-distinct oncogenic initiating events may determine tumor fate in the thyroidJames A Fagin
Medicina|June 22, 2002
[Thyroid cancer: epidemiology and predisposing mechanisms due to ionizing radiation]J A Fagin
Transactions of the American Clinical and Climatological Association|March 25, 2006
Genetics of papillary thyroid cancer initiation: implications for therapyJames A Fagin
The Journal of Endocrinology|November 9, 2004
How thyroid tumors start and why it matters: kinase mutants as targets for solid cancer pharmacotherapyJ A Fagin
The Journal of Clinical Endocrinology and Metabolism|September 10, 2004
Challenging dogma in thyroid cancer molecular genetics--role of RET/PTC and BRAF in tumor initiationJames A Fagin
Medicina|June 13, 2002
Mouse genetic models to explore the function of IGF-I in smooth muscleJ A Fagin
Endocrinology|May 22, 2002
Perspective: lessons learned from molecular genetic studies of thyroid cancer--insights into pathogenesis and tumor-specific therapeutic targetsJames A Fagin
Journal of Endocrinological Investigation|February 1, 1995
Tumor suppressor genes in human thyroid neoplasms: p53 mutations are associated undifferentiated thyroid cancersJ A Fagin
The Journal of Clinical Endocrinology and Metabolism|December 1, 1992
Genetic basis of endocrine disease 3: Molecular defects in thyroid gland neoplasiaJ A Fagin
Pageof 27

Showing results (1-10 of 261) with videos related to

Sort By:
Pageof 27
Public Policy|January 1, 1976
The policy implications of predictive decision-making: "likelihood" and "dangerousness" in civil commitment proceedingsA Fagin
Molecular Endocrinology (Baltimore, Md.)|May 1, 2002
Minireview: branded from the start-distinct oncogenic initiating events may determine tumor fate in the thyroidJames A Fagin
Medicina|June 22, 2002
[Thyroid cancer: epidemiology and predisposing mechanisms due to ionizing radiation]J A Fagin
Transactions of the American Clinical and Climatological Association|March 25, 2006
Genetics of papillary thyroid cancer initiation: implications for therapyJames A Fagin
The Journal of Endocrinology|November 9, 2004
How thyroid tumors start and why it matters: kinase mutants as targets for solid cancer pharmacotherapyJ A Fagin
The Journal of Clinical Endocrinology and Metabolism|September 10, 2004
Challenging dogma in thyroid cancer molecular genetics--role of RET/PTC and BRAF in tumor initiationJames A Fagin
Medicina|June 13, 2002
Mouse genetic models to explore the function of IGF-I in smooth muscleJ A Fagin
Endocrinology|May 22, 2002
Perspective: lessons learned from molecular genetic studies of thyroid cancer--insights into pathogenesis and tumor-specific therapeutic targetsJames A Fagin
Journal of Endocrinological Investigation|February 1, 1995
Tumor suppressor genes in human thyroid neoplasms: p53 mutations are associated undifferentiated thyroid cancersJ A Fagin
The Journal of Clinical Endocrinology and Metabolism|December 1, 1992
Genetic basis of endocrine disease 3: Molecular defects in thyroid gland neoplasiaJ A Fagin
Pageof 27